跳至主要内容
临床试验/JPRN-UMIN000021558
JPRN-UMIN000021558已完成2 期

A Phase II Clinical Trial of Carbon-Ion Therapy for Hepatocellular Carcinoma - Carbon-ion radiotherapy for hepatocytecarcinoma (iROCK-1601LI)

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization0 个研究点目标入组 26 人开始时间: 2016年3月24日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
26

研究概览

简要总结

This study confirmed safety and efficacy comparable to those reported from prior facilities.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Active double cancer 2) Past history of radiotherapy for the target lesion 3) Patient with gastroesophageal varix should be treated 4) 38 degrees celsius or higher of fever, except for tumor fever, or infection which requires systemic therapy 5) Pregnant women, women who may become pregnant, women who deliver with 28 days or lactating women 6) Patient who is difficult to participate this study due to psychiatric condition, uncontrolled heart disease or severe pulmonary disease 7) Patient who is not suitable to participate this study in accordance with physician's examination

研究者

发起方
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

相似试验